Bottle Label 600 mg (71610 0463 30)
Gabapentin
Product Images NDC 71610-463
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 71610-463). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure 1 (Image 01)
This appears to be a chart or graph of some sort showing different pain scores and dose titrations. The chart includes a baseline and spans multiple weeks. The treatments being compared include a placebo and a medication called Gabapentin taken at a dose of 3600 mg/day. However, without more context or information it is difficult to determine what the chart is specifically measuring or evaluating.*
Figure 2 (Image 02)
This is a graph showing the results of a 4-week fixed dose period study of Gabapentin for pain relief. The doses used were a placebo, 1800mg/day and 2400mg/day of Gabapentin. The mean pain score was measured over the course of the 4 weeks. There are no further details provided in the text.*
Figure 3 (Image 03)
Cockcroft And Gault Equation (Image 04)
Gabapentin Structural Formula (Image 05)
Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Image 09)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
